Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|May 11, 2026
Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancerRahul Aggarwal, Jingsong Zhang, Paul Monk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
European Urology Oncology|December 10, 2023
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate CancerEric J Small, Kim N Chi, Simon Chowdhury, et al.
The Journal of Urology|December 26, 2023
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk StratificationLeander Van Neste, Ricardo Henao, Kirk J Wojno, et al.
Urologic Oncology|May 21, 2020
Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) membersJustin T Matulay, William Tabayoyong, Jonathan J Duplisea, et al.
Journal for Immunotherapy of Cancer|April 23, 2015
Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study resultsAsim Amin, Arkadiusz Z Dudek, Theodore F Logan, et al.
The Journal of Urology|December 5, 2025
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End PointsNeal D Shore, Ugo De Giorgi, Ronald F Tutrone, et al.
British Journal of Cancer|November 11, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTANJohn Shen, Simon Chowdhury, Neeraj Agarwal, et al.
BMC Health Services Research|July 26, 2020
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approachCheryl T Lee, Nihal E Mohamed, Sailaja Pisipati, et al.
JAMA|May 26, 2018
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical TrialEdward M Messing, Catherine M Tangen, Seth P Lerner, et al.
Pageof 4